In our study, high YKL-40 intratumoral expression was also significantly more prevalent breast cancer patients with metastases compared with patients who did not have metastatic disease, which agrees with the studies of Johansen et al, and Jensen et al. [17], [18]. This evidence concerns the gene CHI3L1 and breast carcinoma.